Nomi New Medical Technology
Nanos Medical is a Healthcare Company
About Nomi New Medical Technology
Nomi New Medical Technology, officially known as Nanos Medical (Shanghai) Limited, is a Chinese medical device company established in 2015 with its headquarters in Shanghai. The company was founded by Terry Cui, who serves as the chairman. Cui's background is not in medicine but in business and investment; after an early entrepreneurial success, he studied at the Wharton School of the University of Pennsylvania, worked as a consultant for Boston Consulting Group, and was a Vice President at CITIC Capital, focusing on healthcare investments. This experience informed the rational, business-driven decision to enter the Ear, Nose, and Throat (ENT) medical device sector.
The company's strategic growth is propelled by a three-pronged approach: in-house research and development, licensing-in foreign technologies, and mergers and acquisitions. This strategy has led to significant expansion, including the establishment of an R&D and manufacturing base in Suzhou in 2017 and a series of key acquisitions. Notable acquisitions include Chengdu Mechan, a medical plasma technology platform, in 2019; a controlling stake in Hangzhou Tonglu Sike Medical Instrument Co. in 2021; and the complete acquisition of German endoscopy system manufacturer Endodoctor in 2022. These moves have contributed to a compound annual growth rate of over 200% in the past five years and have transformed the firm from a startup into a group company with an international footprint.
Nanos Medical develops, manufactures, and sells a comprehensive portfolio of medical devices focused on otorhinolaryngology (ENT) and minimally invasive surgery, serving hospitals and clinics. The business model integrates R&D, production, and sales to provide a full range of diagnostic and treatment solutions. Its product line is extensive, featuring items such as a Low-Temperature Plasma Surgery System, sinus balloon catheters, eustachian tube balloons, drug-eluting stents, and various surgical instruments. The company also acts as a commercial transformation platform, introducing advanced international technologies into the Chinese market, such as Korean ENT diagnostic units and Swedish rhinitis treatment instruments. Revenue is generated through the sale of these devices and systems to medical institutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 18.0/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Hospital, Hard Tech
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Feb 2025 | $41M | $165M | River Head Capital · Qiming Venture Partners | ↗ |
| SERIES B✓Equity / VC | Jul 2019 | $0 | — | Eight Roads Ventures | — |
Growth signals
Latest recorded traffic for Nomi New Medical Technology is 2.2K monthly website visits, down 8.3% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Nomi New Medical Technology in the Huangpu ecosystem
The Nomi New Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- ACAdvantech Capital
- MPMarathon Venture Partners
Eight Roads Ventures
Series B and later2 investors entered at this stage
Qiming Venture Partners
River Head Capital
Other known investors2 additional known investors
6 Dimensions Capital
F-Prime
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nomi New Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nomi New Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









